Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marielle König-Schuster"'
Autor:
Sabine Nakowitsch, Christiane Koller, Jan-Marcus Seifert, Marielle König-Schuster, Nicole Unger-Manhart, Cornelia Siegl, Norman Kirchoff, Elisabeth Foglar, Christine Graf, Martina Morokutti-Kurz, Marianne Neurath, Svenja Sladek, Christian Knecht, Wolfgang Sipos, Eva Prieschl-Grassauer, Andreas Grassauer
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 847 (2020)
Due to fast nasal mucociliary clearance, only the dissolved drug content can effectively permeate the mucosa and be pharmaceutically active after intranasal application of suspensions. Therefore, the aim of this study was to increase the budesonide c
Externí odkaz:
https://doaj.org/article/f4b3eab3baa741a3ab8edd0179a444ed
Autor:
Martina Morokutti-Kurz, Marielle König-Schuster, Christiane Koller, Christine Graf, Philipp Graf, Norman Kirchoff, Benjamin Reutterer, Jan-Marcus Seifert, Hermann Unger, Andreas Grassauer, Eva Prieschl-Grassauer, Sabine Nakowitsch
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128794 (2015)
Carrageenan is a clinically proven and marketed compound for the treatment of viral upper respiratory tract infections. As infections caused by influenza virus are often accompanied by infections with other respiratory viruses the combination of a sp
Externí odkaz:
https://doaj.org/article/53c29c16074c4287bf2fbd5f33f20f5a
Autor:
Andreas Leibbrandt, Christiane Meier, Marielle König-Schuster, Regina Weinmüllner, Donata Kalthoff, Bettina Pflugfelder, Philipp Graf, Britta Frank-Gehrke, Martin Beer, Tamas Fazekas, Hermann Unger, Eva Prieschl-Grassauer, Andreas Grassauer
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e14320 (2010)
The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated
Externí odkaz:
https://doaj.org/article/5c68f0bb902f422592a8cf34b599071b
Autor:
Marielle König-Schuster, Philipp Graf, Eva Prieschl-Grassauer, Cornelia Siegl, Nicole Unger-Manhart, Sabine Nakowitsch, Christiane Koller, Christian Knecht, Wolfgang Sipos, Norman Kirchoff, Yvonne Schindlegger
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 134:88-95
Corticosteroids and macrolide immunomodulators such as tacrolimus are effective drugs for the topical treatment of inflammatory eye diseases like allergic conjunctivitis or dry eye. However, tacrolimus is practically insoluble in aqueous solutions an
Autor:
Cornelia Siegl, Sabine Nakowitsch, Nicole Unger-Manhart, Christine Graf, Norman Kirchoff, Jan-Marcus Seifert, Martina Morokutti-Kurz, Marianne Neurath, Christian Knecht, Svenja Sladek, Eva Prieschl-Grassauer, Marielle König-Schuster, Christiane Koller, Andreas Grassauer, Wolfgang Sipos, Elisabeth Foglar
Publikováno v:
Pharmaceutics, Vol 12, Iss 847, p 847 (2020)
Pharmaceutics
Volume 12
Issue 9
Pharmaceutics
Volume 12
Issue 9
Due to fast nasal mucociliary clearance, only the dissolved drug content can effectively permeate the mucosa and be pharmaceutically active after intranasal application of suspensions. Therefore, the aim of this study was to increase the budesonide c
Autor:
Christine Graf, Jan-Marcus Seifert, Norman Kirchoff, Martina Morokutti-Kurz, Philipp Graf, Andreas Grassauer, Benjamin Reutterer, Eva Prieschl-Grassauer, Hermann Unger, Sabine Nakowitsch, Christiane Koller, Marielle König-Schuster
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128794 (2015)
PLoS ONE
PLOS ONE
PLoS ONE
PLOS ONE
Background Carrageenan is a clinically proven and marketed compound for the treatment of viral upper respiratory tract infections. As infections caused by influenza virus are often accompanied by infections with other respiratory viruses the combinat
Autor:
Regina Weinmüllner, Philipp Graf, Martin Beer, Britta Frank-Gehrke, Christiane Meier, Hermann Unger, Andreas Leibbrandt, Andreas Grassauer, Donata Kalthoff, Marielle König-Schuster, Tamas Fazekas, Eva Prieschl-Grassauer, Bettina Pflugfelder
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e14320 (2010)
PLoS ONE, Vol 5, Iss 12, p e14320 (2010)
The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated
Autor:
Bernhard Binishofer, Sonja Schwab, Brian Salmons, Chukwuma A. Agu, Udo Bläsi, Walter H. Günzburg, Michael Ausserlechner, Petra Kodajova, Christine Hohenadl, Reinhard Klein, Marielle König-Schuster
Publikováno v:
The journal of gene medicine. 8(2)
Background The potential use of gene therapy for cancer treatment is being intensively studied. One approach utilises the expression of genes encoding cytotoxic proteins. Such proteins can affect cellular viability, for example by inhibiting the tran